Role of transforming growth factor beta-1(TGF-β1) in pathogenesis of Trichomonas vaginalis

Author:

Huda Abdullah ,Kawther Abdul-Hussain Mahdi Al-Mussawi

Abstract

Trichomoniasis caused by the parasiteTrichomonas vaginalisis the most common non-viral, curable sexually transmitted disease worldwide that annually affects millions of people. It was found that several immunologic and biochemical factors play a role in the pathogenesis of Trichomonas vaginalis. In this study, we aimed to investigate the role of transforming growth factor beta-1(TGF-β1) in the pathogenesis of Trichomonas vaginalis.In this study, vaginal swabs, urine and blood samples were taken from (350) women, whose ages ranged between (15-65) yearsand were attending the women’s obstetrics and gynecology hospital in Karbala province during the period from November 2021 to June 2022. The general urine examination and direct microscopic examination of the vaginal swabs were used to detect the parasite, while the serum (TGF-β1) level was estimated by ELISA technique. A questionnaire form was used to collect information from the participant women including age, residency, marital status, educational level, fertility and using contraceptives.The results showed that only (100) cases were positive for Trichomonas vaginalis, and the highest incidence of positive cases was within the age group (15-24) years and the lowest incidence was within the age group (55-65) years. The number and percentage of positive women from rural areas was 49 (28.49%), while the number and percentage of positive women from urban areas was 51 (28.65%), with no significant difference (P=0.973). The mean and standard deviation of serum TGF-β1 was (22.06±10.74) in the healthy non-infected women, while the mean and standard deviation of serum TGF-β1 was (97.93±28.6) in the patient infected women, with a highly significant difference (P<0.001).It can be concluded from the current study that the levels of serum TGF-β1 was highly increased in women infected with Trichomonas vaginalis.

Publisher

Siree Journals

Subject

Drug Discovery,Pharmaceutical Science,Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3